Health Insurance
IRDAI Wants to Cut Your Health Agent's Commission — Here's Why That Could Be Good for You
IRDAI's Sep 23 draft proposes capping health insurance commissions: 20% first-year, 10% on renewals. What it means for your premium, renewals and portability.

On September 23, 2026, the Insurance Regulatory and Development Authority of India (IRDAI) released a two-part consultation paper titled "Recalibrating Economics of Insurance Distribution" — and it takes direct aim at how health insurance is sold in India. The proposals put hard caps on the commissions agents, banks and brokers earn from health policies, and this week the industry pushed back: life and general insurers met the regulator around September 30 seeking a softer glide path, while the brokers' apex body publicly warned the reforms could hurt policyholders and jobs.
Stakeholder comments are open until October 25, 2026, so nothing is final yet. But the direction is unmistakable — and if you hold a health insurance policy, or plan to buy one, this draft affects the economics of your next renewal. Here is what IRDAI has proposed, in plain language.
What IRDAI has proposed — the numbers
The draft proposes the following caps on commissions for health insurance: - Individual health policies sold by agents and associates: commission capped at 20% of the premium in the first year, 10% on renewals, and 10% on portability (when you move your policy to another insurer). - The same policies sold through distribution entities such as banks, brokers and corporate agents: 15% in the first year, and 5% on renewals and portability. - Group health insurance: commission capped at 2.5%, subject to a maximum of ₹10 million. For context, the average commission on group health in FY2025 was 15%, with a maximum of 93%. - Before this draft, first-year commissions on individual health insurance were running at roughly 24% — the proposal brings that down to 15–20% depending on the channel. - Separately, the Expenses of Management (EoM) limit for standalone health insurers is proposed to fall from 35% to 30%. EoM is the regulatory ceiling on how much of the premium pool an insurer can spend on running the business, including distribution costs. Every one of these is a proposal in a consultation paper — not a final rule. The final norms, due after the October 25 comment window closes, may look different.How health insurance commissions work today
To understand why this matters, it helps to see where your premium goes. When you pay, say, ₹25,000 a year for a family floater, you do not pay your agent separately. The insurer carves a slice out of your premium and pays it to the agent, bank or broker who sold you the policy. The commission is baked into the price every policyholder pays. First-year commissions are always the highest — that is the "acquisition" reward for bringing in a new customer. Renewal commissions are lower, but under the current structure they are still meaningful enough that distributors have a financial reason to keep you renewing through them — and, in some cases, to churn you between insurers to earn a fresh first-year payout. That churning incentive is exactly what the proposed 10% and 5% caps on portability commissions are designed to kill. Portability itself is an existing IRDAI right: at renewal, you can move your health policy to another insurer without losing continuity benefits such as waiting-period credit for pre-existing diseases. The draft does not touch that right — it only changes what the distributor earns when you exercise it.Why IRDAI is doing this
The regulator's context is written in its own data. Grievances in general insurance rose from 78,347 in FY2023 to 137,361 in FY2025 — nearly doubling in two years. And the scale of distribution payouts keeps climbing: life insurers paid ₹60,799 crore in commissions in FY2025, up 18% year-on-year from ₹51,524 crore in FY2024. IRDAI's stated objective, as reported in the coverage of the draft, is to curb misselling and improve transparency in how insurance is distributed. High upfront commissions create a well-documented conflict: the person advising you on which policy to buy earns the most from the most expensive sale, not the most suitable one. Capping that payout is the regulator's way of defusing the conflict at its source. This is also part of a wider reform wave. Earlier in 2026, individual health and life insurance policies were exempted from 18% GST — a direct relief to policyholders. The distribution draft is the second half of that story: after cutting the tax on premiums, the regulator is now squeezing the cost of selling them.What it could mean for your premium
Let us be honest about what a commission cap can and cannot do. A cap on distribution costs does not automatically cut your premium. Your health insurance price is driven mainly by medical inflation, the insurer's claims experience, your age, and your sum insured — none of which this draft touches. What it can do is structural and slow. Distribution cost is a real slice of every premium rupee. If that slice shrinks permanently, insurers gain room to price more competitively over time — room, not a promise. The more immediate benefit for policyholders is likely to be behavioural: with thinner upfront payouts, the incentive to push the priciest policy in the brochure weakens, and renewal conversations can become more about your cover and less about the distributor's earnings. One caution: proposals sometimes produce the opposite of their intent in the short run. If distribution becomes less remunerative, some intermediaries may exit or consolidate, which the brokers' body IBAI has flagged as a risk to service quality. That is a genuine trade-off to watch, not a reason to panic.Renewals and portability — what to watch
The renewal and portability caps are the quietest but potentially most consumer-friendly part of the draft. Today, a distributor who moves you to a new insurer at renewal can earn a first-year-style payout on what is, for you, simply a continuation of cover. Capping portability commissions at 10% (agents) and 5% (entities) removes the arbitrage in churning. If the proposals are finalised broadly as drafted, expect two practical shifts over time: renewal notices that compete more on coverage terms than on relationship pressure, and portability advice driven more by which insurer suits you than by which one pays the introducer best. "Over time" matters — distribution contracts and insurer systems do not rewire overnight.3 things to check before your next renewal
Whether or not the draft becomes law in its current form, the consultation window is a good moment to review your own policy with fresh eyes: 1. Compare on cover, not premium alone. Sum insured, room-rent limits, waiting periods for pre-existing diseases, and the exclusions list matter far more than a ₹1,000 difference in annual premium. 2. Check the insurer's track record. IRDAI's annual report publishes claim settlement ratios and grievance data — a cheap policy from an insurer that fights claims is no bargain. 3. Do not let anyone rush you with "buy before the rules change." No rule has changed yet; the paper is in consultation until October 25. Any pitch that uses the draft to create urgency is a sales tactic, not information.The industry is pushing back — both sides, fairly stated
The Insurance Brokers Association of India (IBAI), the apex body for the country's 798 licensed brokers, has publicly warned that the reforms could hurt policyholders, cost jobs and slow insurance growth — while also saying it supports the objectives of curbing misselling and improving transparency. Separately, life and general insurers met IRDAI around September 30 to seek a softer glide path for the proposed expense limits. Both positions are legitimate inputs to a consultation process, which is exactly what the October 25 window is for. The final norms will reflect how the regulator weighs consumer benefit against distribution viability. For policyholders, the useful takeaway is not which side "wins" but that the economics of how your policy is sold are being renegotiated in public — for the first time in years.What happens next
Stakeholder comments close on October 25, 2026. IRDAI will then finalise the norms, and the final version may differ materially from the draft — caps could be phased, thresholds adjusted, or timelines extended. Existing policies are contracts already in force; a consultation paper changes nothing about them today. If you are buying or renewing in the next few months, make the decision on today's rules and today's prices, and treat the draft as context for what the market may look like a year from now. This article is for educational purposes only and is not financial advice. Please consult a SEBI-registered investment adviser for personalized guidance. Investments are subject to market risk.Frequently Asked Questions
Will my health insurance premium fall because of this draft?
Is this rule final?
Does the draft affect my existing health insurance policy?
What is Expenses of Management (EoM)?
Can I still port my health policy to another insurer?
Should I wait to buy health insurance until the final rules come out?
Your next step
Before your next renewal, pull up your policy document and answer three questions in writing: is my sum insured still enough for a private hospital in my city, what are my waiting periods and exclusions, and what is my insurer's claim settlement record? If you cannot answer all three, that review — not any regulatory draft — is the most valuable thing you can do this week.
Learn MoreDiscussion
KEEP EXPLORING
More in Health Insurance Your next good read.
Health Insurance
What Is a Super Top-Up Health Plan? The ₹4,000-a-Year Way to Turn ₹5 Lakh Cover Into ₹20 Lakh (2026)
7 min read
Health InsuranceSenior Citizen Health Insurance After 60: the 10% Premium Cap, Its Loophole, and What Your Parents' Cover Really Costs
9 min read
Health InsuranceHealth Insurance GST Is Zero Now — But Your Premium Still Rose. Where Did the 18% Go?
7 min read